Lumida
/KYTX
⌘K
Kyverna Therapeutics Inc

Kyverna Therapeutics Inc

KYTX
$7.26USD-1.22%-0.09 today

MARKET CAP

449.0M

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $8

52W RANGE

$4
$14

Buying

4

institutions

Selling

7

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY3.13 M27.93 M+2.26 M+269.0%0.00%
WP

Woodline Partners LP

Q2 2026

SELL845.33 K7.53 M+-845.33 K-48.4%0.02%
MM

Millennium Management LLC

Q2 2026

SELL639.78 K5.70 M+-365.73 K-34.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL333.90 K2.98 M+-33.59 K-6.2%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY321.93 K2.87 M+234.30 K+279.3%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL96.05 K855.79 K+-1.03 M-91.2%0.00%
MG

Man Group Plc

Q2 2026

BUY68.64 K611.58 K+15.10 K+32.4%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY22.98 K201.81 K+18.31 K+469.5%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-222.93 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-63.52 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-22.43 K-100.0%0.00%